CASE STUDY

WuXi AppTec

Pharmaceutical and Medical Technology Leader Meets High Regulatory Standards with CERDAAC

Summary

WuXi AppTec has demonstrated outstanding achievement in technological innovation. As part of their dedication to industry excellence, the company must keep its pharmaceutical and medical device tools and equipment in top condition and precisely calibrated. To help achieve those standards of excellence, WuXi AppTec uses SIMCO’s CERDAAC software.

As part of the evaluation process, SIMCO provided WuXi AppTec with a business case detailing the savings SIMCO’s CERDAAC software would provide over the company’s current approach:

  • 477% Return on Investment
  • $148,550 savings annually
  • ~1000 hours saved in audit support

“There is a huge reduction in the amount of time we spend because we no longer have to maintain multiple databases. We definitely are making much more efficient use of resources with CERDAAC.”

— Lukin Moline
Validation Specialist

About WuXi AppTec

WuXi AppTec is a leading global pharmaceutical and medical device open-access technology company with operations in 30 countries worldwide. Founded as a single laboratory, WuXi today has 27 locations and over 1,800 employees. The company’s mission is to build an open-access platform with the most comprehensive capabilities and technologies in the global healthcare industry, with the goal that “every drug can be made and every disease can be treated.”